Olive AI

Olive AI launched their MVP in 2017 as a narrow bot targeting prior authorization—the most painful administrative bottleneck in hospitals. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌They shipped quickly, deliberately omitting the broader "internet of healthcare" vision to focus on one repeatable workflow. This laser focus initially worked; early deployments showed hospitals could deploy bots within weeks rather than months. However, Olive's execution masked a fatal flaw: unit economics. Each bot required extensive customization for different hospital systems, EHR integrations, and payer networks. What appeared as rapid shipping actually concealed mounting implementation costs that didn't scale. The company kept adding features and bots—claims processing, eligibility verification, billing—without proving the core unit economics worked. By 2024, despite raising $400+ million, Olive laid off 50% of staff and paused new customer acquisition, revealing that their execution velocity had outpaced their ability to build a sustainable business model. The warning sign was ignored: early customers required disproportionate engineering resources relative to revenue generated.